Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance
In Vivo · 2024 · 38 (3) · 1300-1305
DOI: 10.21873/invivo.13569 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, online erschienen am 30.04.2024. Verfasst von Pietro Pepe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Urology Unit, Cannizzaro Hospital, Catania, Italy; piepepe@hotmail.com. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Neoplasm Grading, Watchful Waiting. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology Unit, Cannizzaro Hospital, Catania, Italy; piepepe@hotmail.com.
- Urology Unit, Cannizzaro Hospital, Catania, Italy.
- Pathology Unit, Gravina and S. Pietro Hospital, Caltagirone, Italy.
Zitieren
APA
Pepe, P., Pepe, L., Pennisi, M., & Fraggetta, F. (2024). Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance. In Vivo, 38(3), 1300-1305. https://doi.org/10.21873/invivo.13569
Vancouver
Pepe P, Pepe L, Pennisi M, Fraggetta F. Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance. In Vivo. 2024;38(3):1300-1305. doi:10.21873/invivo.13569
BibTeX
@article{Pepe2024,
author = {Pepe, Pietro and Pepe, Ludovica and Pennisi, Michele and Fraggetta, Filippo},
title = {Oncological Outcomes in Men With Favorable Intermediate Risk Prostate Cancer Enrolled in Active Surveillance},
journal = {In Vivo},
year = {2024},
volume = {38},
number = {3},
pages = {1300--1305},
doi = {10.21873/invivo.13569}
}
EUVIMED